[{"data":1,"prerenderedAt":134},["ShallowReactive",2],{"drug-azelastine-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":20,"regimens":33,"contraindications":50,"warnings":60,"renal":61,"monitoring":62,"interactions":63,"review":64,"examples":67,"atc":73,"iran":75,"usApproval":82,"links":88,"populations":99},"azelastine-eye",1,{"fa":7,"en":8},"قطره چشمی آزلاستین","Azelastine eye drops","sensory-organs",{"fa":11,"en":12},"آنتی‌هیستامین چشمی","Ophthalmic antihistamine",[14],{"name":15,"market":16},"Optivar","US",[18,19],"optivar","آزلاستین چشمی",[21],{"id":22,"form":23,"route":24,"label":25,"concentration":26,"markets":28,"refs":29},"drops","eye-drops","ophthalmic","0.05% ophthalmic solution",{"amount":5,"unit":27,"perUnit":27},"drop",[16],[30],{"source":31,"section":32},"fda-azelastineeye","How Supplied",[34],{"id":35,"disease":36,"label":37,"population":40,"type":44,"unit":27,"dose":45,"refs":47},"ac","allergic-conjunctivitis",{"fa":38,"en":39},"خارش چشم آلرژیک — ۱ قطره دو بار در روز (۳ سال به بالا)","Allergic itching — 1 drop twice daily (≥3 y)",{"minAge":41},{"value":42,"unit":43},3,"year","fixed",{"perDose":5,"dosesPerDay":46},2,[48],{"source":31,"section":49},"Dosage and Administration",[51],{"id":52,"severity":53,"text":54,"refs":57},"hyper","block",{"fa":55,"en":56},"حساسیت به اجزا.","Hypersensitivity to components.",[58],{"source":31,"section":59},"Contraindications",[],[],[],[],{"status":65,"reviewer":66,"date":66},"unverified",null,[68],{"regimen":35,"formulation":22,"input":69,"expect":72},{"ageYears":70,"weightKg":71},20,60,{"perDose":5},[74],"S01GX07",{"status":76,"refs":77},"not-found",[78],{"source":79,"section":80,"url":81},"darooyab-generic","search","https:\u002F\u002Fwww.darooyab.ir\u002FSearch?q=Azelastine%20eye%20drops",{"kind":83,"refs":84,"id":87},"ANDA",[85],{"source":31,"section":86},"SPL approval \u002F marketing category","ANDA078621",[89,92,96],{"kind":90,"url":91,"label":87},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=078621",{"kind":93,"url":94,"label":95},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=77a33738-ffcf-221c-1562-780418882e5d","FDA Azelastine eye",{"kind":97,"url":98,"label":74},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01GX07",{"pregnancy":100,"lactation":109,"pediatric":117,"geriatric":125},{"level":101,"text":102,"quote":105,"refs":106},"caution",{"fa":103,"en":104},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Azelastine hydrochloride ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[107],{"source":31,"section":108},"Precautions\u002FWarnings – Pregnancy",{"level":101,"text":110,"quote":113,"refs":114},{"fa":111,"en":112},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Because many drugs are excreted in human milk, caution should be exercised when azelastine hydrochloride ophthalmic solution is administered to a nursing woman.",[115],{"source":31,"section":116},"Precautions\u002FWarnings – Nursing Mothers",{"level":101,"text":118,"quote":121,"refs":122},{"fa":119,"en":120},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness in pediatric patients below the age of 3 have not been established.",[123],{"source":31,"section":124},"Precautions\u002FWarnings – Pediatric Use",{"level":126,"text":127,"quote":130,"refs":131},"ok",{"fa":128,"en":129},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety or effectiveness have been observed between elderly and younger adult patients.",[132],{"source":31,"section":133},"Precautions\u002FWarnings – Geriatric Use",1792100093619]